Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1276
Global Industrial
GIC
$1.66B
| $9.1M | 0.01% |
442,967
+89,900
| +25% | +$1.74M |
2014 Q2
24 quarters
|
|
1277
German American Bancorp
GABC
$1.83B
| $9.09M | 0.01% |
292,400
-33,300
| -10% | -$959K |
2013 Q2
28 quarters
|
|
1278
CEVA Inc
CEVA
$894M
| $9.09M | 0.01% |
242,900
-73,300
| -23% | -$2.35M |
2018 Q4
6 quarters
|
|
1279
RLI Corp
RLI
$5.2B
| $9.08M | 0.01% |
221,200
+4,200
| +2% | +$166K |
2020 Q1
1 quarter
|
|
1280
Tilly's
TLYS
$139M
| $9.06M | 0.01% |
1,597,710
-284,822
| -15% | -$1.47M |
2014 Q4
22 quarters
|
|
1281
China Yuchai International
CYD
$1.06B
| $8.99M | 0.01% |
625,107
+88,824
| +17% | +$1.11M |
2015 Q3
19 quarters
|
|
1282
Peoples Bancorp
PEBO
$1.3B
| $8.98M | 0.01% |
421,979
-88,300
| -17% | -$1.93M |
2013 Q2
28 quarters
|
|
1283
Blue Bird Corp
BLBD
$1.92B
| $8.98M | 0.01% |
598,818
-51,600
| -8% | -$647K |
2016 Q3
15 quarters
|
|
1284
Grupo Aval
AVAL
$5.73B
| $8.96M | 0.01% |
2,054,472
+170,350
| +9% | +$749K |
2015 Q2
20 quarters
|
|
1285
Hewlett Packard
HPE
$93.4B
| $8.95M | 0.01% |
+920,000
| New | +$9.03M |
2020 Q2
0 quarters
|
|
1286
Controladora Vuela Compania de Aviacion
VLRS
$717M
| $8.95M | 0.01% |
1,694,900
-567,600
| -25% | -$2.68M |
2018 Q2
8 quarters
|
|
1287
WaFd
WAFD
$2.18B
| $8.95M | 0.01% |
333,276
-8,800
| -3% | -$227K |
2015 Q3
19 quarters
|
|
|
ACC
1288
DELISTED
American Campus Communities, Inc.
ACC
| $8.94M | 0.01% |
255,628
-244,584
| -49% | -$8.11M |
2013 Q2
28 quarters
|
|
1289
JBG SMITH
JBGS
$648M
| $8.92M | 0.01% |
301,800
+114,400
| +61% | +$3.54M |
2018 Q3
7 quarters
|
|
|
BRG
1290
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $8.9M | 0.01% |
1,101,575
-362,188
| -25% | -$2.41M |
2015 Q1
21 quarters
|
|
1291
Allient
ALNT
$1.81B
| $8.88M | 0.01% |
377,523
-61,950
| -14% | -$1.29M |
2013 Q2
28 quarters
|
|
1292
Nomura Holdings
NMR
$28B
| $8.88M | 0.01% |
2,000,490
-47,700
| -2% | -$198K |
2019 Q1
5 quarters
|
|
1293
Clarivate
CLVT
$1.03B
| $8.87M | 0.01% |
+397,400
| New | +$8.98M |
2020 Q2
0 quarters
|
|
1294
Kamada
KMDA
$452M
| $8.85M | 0.01% |
1,139,945
+159,678
| +16% | +$1.2M |
2013 Q4
26 quarters
|
|
1295
Helen of Troy
HELE
$666M
| $8.85M | 0.01% |
46,910
-20,900
| -31% | -$3.42M |
2020 Q1
1 quarter
|
|
1296
Donegal Group Class A
DGICA
$677M
| $8.84M | 0.01% |
621,811
+28,200
| +5% | +$402K |
2014 Q4
22 quarters
|
|
1297
Industrial Logistics Properties Trust
ILPT
$468M
| $8.83M | 0.01% |
429,880
-160,800
| -27% | -$2.95M |
2019 Q1
5 quarters
|
|
1298
Healthpeak Properties
DOC
$13.1B
| $8.82M | 0.01% |
320,109
+50,307
| +19% | +$1.28M |
2020 Q1
1 quarter
|
|
1299
Orion Energy Systems
OESX
$104M
| $8.82M | 0.01% |
254,879
+18,800
| +8% | +$769K |
2013 Q2
28 quarters
|
|
1300
Galiano Gold
GAU
$565M
| $8.82M | 0.01% |
6,630,479
+1,408,263
| +27% | +$1.58M |
2017 Q3
11 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.